ReviewCancers2022
Emerging Blood-Based Biomarkers for Predicting Immunotherapy Response in NSCLC.
Ana Oitabén et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papertrialcites it
ReviewCancers2022
Ana Oitabén et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.